Cantor Fitzgerald initiated coverage of Acadia Healthcare with a Neutral rating and $83 price target. The analyst expects a step up in the company’s growth trajectory through 2026 as it increases capital deployment for comprehensive treatment center de novo growth, but wants to see its exposure to inpatient psych decline.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on ACHC:
- Street Wrap: Today’s Top 15 Upgrades, Downgrades, Initiations
- Acadia Healthcare downgraded to Sell at Deutsche Bank on CTC business concerns
- Acadia Healthcare downgraded to Sell from Hold at Deutsche Bank
- Acadia Healthcare price target lowered to $75 from $82 at Deutsche Bank
- Acadia Healthcare price target lowered to $80 from $87 at Mizuho
